insights_auto
Why is ORX down 2.47%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 13.40
arrow_downward
-2.47%(-0.34) 1D
Oct 2, 5:29:48 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 14.28
High
SEK 14.28
Low
SEK 13.30
Mkt. cap
470.70M
Avg. vol.
42.95K
Volume
0.00
P/E ratio
0.57
52-wk high
SEK 43.40
52-wk low
SEK 12.20
EPS
SEK 23.61
Shares outstanding
35.13M
No. of employees
61
Open
SEK 14.28
High
SEK 14.28
Low
SEK 13.30
Mkt. cap
470.70M
Avg. vol.
42.95K
Volume
0.00
P/E ratio
0.57
52-wk high
SEK 43.40
52-wk low
SEK 12.20
EPS
SEK 23.61
Shares outstanding
35.13M
No. of employees
61
News stories
From web sources and news partners
Simply Wall Street
·
35 minutes ago
Phase 2 Trial Plans Could Be A Game Changer For Absci Stock (ABSI)
Yahoo Finance
·
1 hour ago
Forget the S&P 500: SCHD Is Beating It by Nearly 10 Points in 2026 and Its Dividend Just Grew
Simply Wall Street
·
35 minutes ago
3 U.S. Consumer Stocks That Could Benefit If Stimulus Checks Return
USA Today
·
12 hours ago
Is a stock market correction coming? Most Americans think so
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB